Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices

BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Add To Watchlist

Recent & Breaking News (NDAQ:BSGM)

BioSig's PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular Arrhythmias

GlobeNewswire October 12, 2021

Clinical Data Acquired by the PURE EP(TM) System Published in the Journal of Cardiac Electrophysiology

GlobeNewswire October 4, 2021

BioSig Selects Plexus Corp. as its Manufacturing Partner

GlobeNewswire September 28, 2021

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

GlobeNewswire September 21, 2021

BioSig Increases Installation Footprint Adding St. Elizabeth's Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

GlobeNewswire September 13, 2021

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

GlobeNewswire August 31, 2021

BioSig's Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium

GlobeNewswire August 19, 2021

BioSig To Host Presentations from Physician Users of its Signal Processing System for Arrhythmia Care during the annual Heart Rhythm 2021 convention

GlobeNewswire July 20, 2021

BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology

GlobeNewswire July 13, 2021

BioSig to Host Conference Call to Unblind Clinical Data Collected with its Signal Processing Technology for Arrhythmia Care

GlobeNewswire July 12, 2021

BioSig Announces Closing of Public Offering of Common Stock

GlobeNewswire July 7, 2021

BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology

GlobeNewswire July 7, 2021

BioSig Announces Pricing of Public Offering of Common Stock

GlobeNewswire July 2, 2021

BioSig Announces Proposed Public Offering of Common Stock

GlobeNewswire July 1, 2021

BioSig Completes 1000 Patient Cases with its Signal Processing System for Electrophysiology

GlobeNewswire June 30, 2021

BioSig's Signal Processing Technology for Electrophysiology To Be Featured During 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

GlobeNewswire June 28, 2021

BioSig's Signal Processing System for Electrophysiology Featured in Two Clinical and Scientific Presentations during the annual Heart Rhythm 2021 convention

GlobeNewswire June 22, 2021

BioSig Technologies, Inc. to Present New Clinical Data at Heart Rhythm 2021 Annual Convention

GlobeNewswire June 15, 2021

BioSig Technologies, Inc. to Present at the LD Micro Invitational XI Virtual Event

GlobeNewswire June 7, 2021

BioSig Technologies, Inc. to Present at the Jefferies Virtual Healthcare Conference

GlobeNewswire May 28, 2021